Browsing by Autor "Juan Carlos Quiroz"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Thumbnail Image
    Item type: Item ,
    A task force for diagnosis and treatment of people with Alzheimer’s disease in Latin America
    (Frontiers Media, 2023) Francisco Lopera; Nilton Custodio; Mariana Rico-Restrepo; Ricardo Allegri; José Domingo Barrientos; Estuardo Garcia Batres; Ismael Luis Calandri; Cristian Moscoso; Paulo Caramelli; Juan Carlos Quiroz
    Alzheimer's disease (AD) represents a substantial burden to patients, their caregivers, health systems, and society in Latin America and the Caribbean (LAC). This impact is exacerbated by limited access to diagnosis, specialized care, and therapies for AD within and among nations. The region has varied geographic, ethnic, cultural, and economic conditions, which create unique challenges to AD diagnosis and management. To address these issues, the Americas Health Foundation convened a panel of eight neurologists, geriatricians, and psychiatrists from Argentina, Brazil, Colombia, Ecuador, Guatemala, Mexico, and Peru who are experts in AD for a three-day virtual meeting to discuss best practices for AD diagnosis and treatment in LAC and create a manuscript offering recommendations to address identified barriers. In LAC, several barriers hamper diagnosing and treating people with dementia. These barriers include access to healthcare, fragmented healthcare systems, limited research funding, unstandardized diagnosis and treatment, genetic heterogeneity, and varying social determinants of health. Additional training for physicians and other healthcare workers at the primary care level, region-specific or adequately adapted cognitive tests, increased public healthcare insurance coverage of testing and treatment, and dedicated search strategies to detect populations with gene variants associated with AD are among the recommendations to improve the landscape of AD.
  • Thumbnail Image
    Item type: Item ,
    Assessing Cognitive Impairment in Quechua and Aymara Patients: A Critical Examination of the Rowland Universal Dementia Assessment Scale’s Discriminative Capacity
    (Wiley, 2024) Marco Málaga; Diego Bustamante‐Paytan; Arturo Jhonny Ruiz‐Yaringaño; Belén Custodio; Marcio F. Soto‐Añari; Maria Fernanda Ore‐Gomez; Juan Carlos Quiroz; María Isabel Cusicanqui; Rosa Montesinos; Nilton Custodio
    The use of the RUDAS in native language speakers and its ability to distinguish between Mild Cognitive Impairment (MCI) and dementia raise some concerns. To improve assessments for various communities in Latin America and the Caribbean, there is a need for culturally adapted brief cognitive tests.
  • Thumbnail Image
    Item type: Item ,
    Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
    (Adis, Springer Healthcare, 2019) Judith Steinberg; Yára Dadalti Fragoso; Juan Carlos Quiroz; Juan Raul García; Caroline Guerra; Virginia Jiménez Rodríguez; Claudia Rodríguez; Ethel Ciampi; Edgar Patricio Correa‐Díaz; Miguel Ángel Macías-Rodríguez